Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -52.81 | -6.57617832015 | 803.05 | 808.98 | 711.4001 | 6154183 | 743.97236627 | CS |
4 | -147.47 | -16.4273540453 | 897.71 | 907.98 | 711.4001 | 5343228 | 805.29431964 | CS |
12 | -204.75 | -21.4400150787 | 954.99 | 969.6499 | 711.4001 | 3415952 | 856.30832208 | CS |
26 | -41.76 | -5.27272727273 | 792 | 972.53 | 711.4001 | 3269954 | 863.7766383 | CS |
52 | 152.34 | 25.4791771199 | 597.9 | 972.53 | 561.65 | 3106505 | 786.68262895 | CS |
156 | 488.02 | 186.110899245 | 262.22 | 972.53 | 231.87 | 3042334 | 512.30237375 | CS |
260 | 635.54 | 554.088927637 | 114.7 | 972.53 | 113.29 | 3278559 | 361.45708499 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관